Moreover, the apparent heterogeneity in SPP1+ TAMs, ranging from terminally differentiated subsets to potentially intermediate phenotypes, not only highlights the need for further investigation into their ontogeny and functional plasticity, but also positions them as potential targets for therapeutic intervention in CRC. This evidence concerns the gene SPP1 and colorectal carcinoma.